Companies / Consumer Staples
BG
Bunge Global
Agricultural Products & Services
Agricultural Products & ServicesAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health25
Growth33
Profitability26
Cash generation0
Balance sheet24
Dilution control40
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)24.7%Revenue growth (FY)9.0%Revenue CAGR (3y)-7.0%Gross margin20.1%Operating margin—Net margin4.8%Free cash flow margin-5.2%R&D / revenue0.2%Stock comp / revenue0.4%Net debt / operating cash flow16.89xCurrent ratio1.61Diluted share count change17.0%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $16.8B | $21.1B | $17.8B | $15.6B | $16.9B |
| Gross profit | $3.4B | $3.7B | $4.8B | $3.4B | $3.4B |
| Net income | $2.1B | $1.6B | $2.2B | $1.1B | $816M |
| Operating cash flow | -$2.9B | -$5.5B | $3.3B | $1.9B | $844M |
| Capital expenditure | $399M | $555M | $1.1B | $1.4B | $1.7B |
| Free cash flow | -$3.3B | -$6.1B | $2.2B | $524M | -$879M |
| R&D | $33M | $33M | $35M | $30M | $28M |
| Stock-based comp | $61M | $65M | $69M | $65M | $73M |
| Buybacks | $100M | $200M | $600M | $1.1B | $551M |
| Dividends | $289M | $349M | $383M | $378M | $459M |
| Cash | $902M | $1.1B | $2.6B | $3.3B | $1.1B |
| Total debt | — | $5.5B | $4.9B | $6.9B | $15.4B |
| Equity | $7.8B | $9.2B | $10.9B | $9.9B | $15.9B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.